Irina Ianache, Agata Skrzat-Klapaczynska, David Jilich, Lukas Fleischhans, Ivana Gmizic, Jovan Ranin, Antonios Papadopoulos, Konstantinos Protopapas, Velida Mulabdic, Botond Lakatos, Eva Livia Nagy, Josip Begovac, Tiberiu Holban, Dilek Yildiz Sevgi, Alma Cicic, Nina Yancheva, Lubomir Sojak, Nino Rukhadze, Justyna Kowalska, Cristiana Oprea
BACKGROUND: The aim of the study was to assess socio-demographical characteristics, clinical presentation, and outcomes in patients diagnosed with mpox. METHODS: A survey on patients diagnosed with mpox was performed in 14 countries from Central and Eastern Europe. Data was compared according to HIV status and country of origin (EU vs. non-EU). Mpox diagnosis was confirmed by RT-PCR from oropharyngeal swabs, skin lesions, and other body fluids. RESULTS: Out of 154 patients confirmed with mpox in 2022, 99...
April 2, 2024: Travel Medicine and Infectious Disease